Literature DB >> 22786748

Immunodeficiency, centromeric instability, facial anomalies (ICF) syndrome, due to ZBTB24 mutations, presenting with large cerebral cyst.

Manuela Cerbone1, Jun Wang, Silvère M Van der Maarel, Alessandra D'Amico, Antonio D'Agostino, Alfonso Romano, Nicola Brunetti-Pierri.   

Abstract

The immunodeficiency, centromeric instability, facial anomalies (ICF) syndrome is an autosomal recessive disease presenting with immunodeficiency secondary to hypo- or agamma-globulinemia, developmental delay, and facial anomalies. Centromeric instability is the cytogenetic hallmark of the disorder which results from targeted chromosomal rearrangements related to a genomic methylation defect. We describe a patient carrying a homozygous mutation of the ZBTB24 gene, which has been recently shown to be responsible for ICF syndrome type 2. Our patient presented with intellectual disability, multiple café-au-lait spots, and a large cerebral arachnoidal cyst. Although laboratory signs of impaired immune function, such as reduced serum IgM were detected, our patient did not present clinical manifestations of immunodeficiency. Brain malformations abnormalities have not been reported so far in ICF syndrome and it can be speculated that ZBTB24 mutations may alter cerebral development. Nevertheless, we cannot rule out that the presence of the cerebral cyst in the patient is coincidental. In summary, our patient illustrates that clinical evidence of immunodeficiency is not a universal feature of ICF2 syndrome type 2 and suggests that brain malformations may be present in other ICF cases.
Copyright © 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22786748      PMCID: PMC3402683          DOI: 10.1002/ajmg.a.35486

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  15 in total

1.  Macrophage activation syndrome mimicking life-threatening infection in a patient with variable immunodeficiency, centromeric instability, and facial anomalies.

Authors:  Nicolas André; Bertrand Roquelaure; Mathilde Caillez; Marianne Chrestian; Anne Moncla; Carla Blanco-Betancourt; Claudine Schiff
Journal:  Pediatrics       Date:  2004-10       Impact factor: 7.124

2.  ICF syndrome: high variability of the chromosomal phenotype and association with classical Hodgkin lymphoma.

Authors:  C Schuetz; G Barbi; T F E Barth; M Hoenig; A Schulz; P Möeller; D Smeets; J C de Greef; S M van der Maarel; W Vogel; K-M Debatin; W Friedrich
Journal:  Am J Med Genet A       Date:  2007-09-01       Impact factor: 2.802

3.  Multibranched chromosomes 1, 9, and 16 in a patient with combined IgA and IgE deficiency.

Authors:  L Tiepolo; P Maraschio; G Gimelli; C Cuoco; G F Gargani; C Romano
Journal:  Hum Genet       Date:  1979-10-01       Impact factor: 4.132

4.  The DNMT3B DNA methyltransferase gene is mutated in the ICF immunodeficiency syndrome.

Authors:  R S Hansen; C Wijmenga; P Luo; A M Stanek; T K Canfield; C M Weemaes; S M Gartler
Journal:  Proc Natl Acad Sci U S A       Date:  1999-12-07       Impact factor: 11.205

5.  A novel deletion in ZBTB24 in a Lebanese family with immunodeficiency, centromeric instability, and facial anomalies syndrome type 2.

Authors:  E Chouery; J Abou-Ghoch; S Corbani; N El Ali; R Korban; N Salem; C Castro; S Klayme; M Azoury-Abou Rjeily; R Khoury-Matar; G Debo; M Germanos-Haddad; V Delague; G Lefranc; A Mégarbané
Journal:  Clin Genet       Date:  2011-10-05       Impact factor: 4.438

Review 6.  The ICF syndrome: new case and update.

Authors:  T J De Ravel; E Deckers; P L Alliet; P Petit; J P Fryns
Journal:  Genet Couns       Date:  2001

7.  Clinical spectrum of immunodeficiency, centromeric instability and facial dysmorphism (ICF syndrome).

Authors:  M M Hagleitner; A Lankester; P Maraschio; M Hultén; J P Fryns; C Schuetz; G Gimelli; E G Davies; A Gennery; B H Belohradsky; R de Groot; E J A Gerritsen; T Mattina; P J Howard; A Fasth; I Reisli; D Furthner; M A Slatter; A J Cant; G Cazzola; P J van Dijken; M van Deuren; J C de Greef; S M van der Maarel; C M R Weemaes
Journal:  J Med Genet       Date:  2007-09-24       Impact factor: 6.318

8.  DNA methyltransferase 3B (DNMT3B) mutations in ICF syndrome lead to altered epigenetic modifications and aberrant expression of genes regulating development, neurogenesis and immune function.

Authors:  Bilian Jin; Qian Tao; Jinrong Peng; Hui Meng Soo; Wei Wu; Jianming Ying; C Robert Fields; Amber L Delmas; Xuefeng Liu; Jingxin Qiu; Keith D Robertson
Journal:  Hum Mol Genet       Date:  2007-11-20       Impact factor: 6.150

9.  Defective B-cell-negative selection and terminal differentiation in the ICF syndrome.

Authors:  Carla E Blanco-Betancourt; Anne Moncla; Michèle Milili; Yun Liang Jiang; Evani M Viegas-Péquignot; Bertrand Roquelaure; Isabelle Thuret; Claudine Schiff
Journal:  Blood       Date:  2003-11-26       Impact factor: 22.113

Review 10.  Immunodeficiency, centromeric region instability, facial anomalies syndrome (ICF).

Authors:  Melanie Ehrlich; Kelly Jackson; Corry Weemaes
Journal:  Orphanet J Rare Dis       Date:  2006-03-01       Impact factor: 4.123

View more
  7 in total

1.  Genetic, Cellular and Clinical Features of ICF Syndrome: a French National Survey.

Authors:  Delphine Sterlin; Guillaume Velasco; Despina Moshous; Fabien Touzot; Nizar Mahlaoui; Alain Fischer; Felipe Suarez; Claire Francastel; Capucine Picard
Journal:  J Clin Immunol       Date:  2016-02-06       Impact factor: 8.317

2.  Heterogeneous clinical presentation in ICF syndrome: correlation with underlying gene defects.

Authors:  Corry M R Weemaes; Maarten J D van Tol; Jun Wang; Monique M van Ostaijen-ten Dam; Marja C J A van Eggermond; Peter E Thijssen; Caner Aytekin; Nicola Brunetti-Pierri; Mirjam van der Burg; E Graham Davies; Alina Ferster; Dieter Furthner; Giorgio Gimelli; Andy Gennery; Barbara Kloeckener-Gruissem; Stephan Meyn; Cynthia Powell; Ismail Reisli; Catharina Schuetz; Ansgar Schulz; Andrea Shugar; Peter J van den Elsen; Silvère M van der Maarel
Journal:  Eur J Hum Genet       Date:  2013-03-13       Impact factor: 4.246

3.  Immunodeficiency, centromeric region instability and facial anomalies (ICF) syndrome diagnosed in an adult who is now a long-term survivor.

Authors:  Santron Sathasivam; Aran Selvakumaran; Quentin Christopher Jones; Christopher G Wathen
Journal:  BMJ Case Rep       Date:  2013-08-05

4.  Characterization of How DNA Modifications Affect DNA Binding by C2H2 Zinc Finger Proteins.

Authors:  A Patel; H Hashimoto; X Zhang; X Cheng
Journal:  Methods Enzymol       Date:  2016-02-16       Impact factor: 1.600

5.  Combined immunodeficiency develops with age in Immunodeficiency-centromeric instability-facial anomalies syndrome 2 (ICF2).

Authors:  Horst von Bernuth; Ethiraj Ravindran; Hang Du; Sebastian Fröhler; Karoline Strehl; Nadine Krämer; Lina Issa-Jahns; Borko Amulic; Olaf Ninnemann; Mei-Sheng Xiao; Katharina Eirich; Uwe Kölsch; Kathrin Hauptmann; Rainer John; Detlev Schindler; Volker Wahn; Wei Chen; Angela M Kaindl
Journal:  Orphanet J Rare Dis       Date:  2014-10-21       Impact factor: 4.123

6.  A functional assay to classify ZBTB24 missense variants of unknown significance.

Authors:  Haoyu Wu; Kelly K D Vonk; Silvère M van der Maarel; Gijs W E Santen; Lucia Daxinger
Journal:  Hum Mutat       Date:  2019-06-18       Impact factor: 4.878

7.  DNA Methyltransferase 3b in Myeloid Cells Does Not Affect the Acute Immune Response in the Airways during Pseudomonas Pneumonia.

Authors:  Wanhai Qin; Xanthe Brands; Cornelis Van't Veer; Alex F de Vos; Brendon P Scicluna; Tom van der Poll
Journal:  Cells       Date:  2022-02-24       Impact factor: 6.600

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.